nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2A—chronic obstructive pulmonary disease	0.312	1	CbGaD
Lisuride—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.135	0.274	CbGbCtD
Lisuride—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.102	0.208	CbGbCtD
Lisuride—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.102	0.208	CbGbCtD
Lisuride—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.026	0.0529	CbGbCtD
Lisuride—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.026	0.0529	CbGbCtD
Lisuride—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0232	0.0471	CbGbCtD
Lisuride—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0218	0.0444	CbGbCtD
Lisuride—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0147	0.03	CbGbCtD
Lisuride—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0141	0.0286	CbGbCtD
Lisuride—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0125	0.0255	CbGbCtD
Lisuride—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00735	0.015	CbGbCtD
Lisuride—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00694	0.0141	CbGbCtD
Lisuride—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00525	0.374	CbGeAlD
Lisuride—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00191	0.136	CbGeAlD
Lisuride—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.0145	CcSEcCtD
Lisuride—Aggression—Montelukast—chronic obstructive pulmonary disease	0.00132	0.0144	CcSEcCtD
Lisuride—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.0139	CcSEcCtD
Lisuride—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.0138	CcSEcCtD
Lisuride—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.00119	0.013	CcSEcCtD
Lisuride—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.013	CcSEcCtD
Lisuride—Dementia—Prednisone—chronic obstructive pulmonary disease	0.00114	0.0124	CcSEcCtD
Lisuride—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.0122	CcSEcCtD
Lisuride—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.0119	CcSEcCtD
Lisuride—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.0118	CcSEcCtD
Lisuride—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.0116	CcSEcCtD
Lisuride—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.0115	CcSEcCtD
Lisuride—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0112	CcSEcCtD
Lisuride—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.0112	CcSEcCtD
Lisuride—Cabergoline—ADRB2—chronic obstructive pulmonary disease	0.00102	0.222	CrCbGaD
Lisuride—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.000993	0.0108	CcSEcCtD
Lisuride—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.000943	0.0103	CcSEcCtD
Lisuride—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000918	0.01	CcSEcCtD
Lisuride—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000903	0.00986	CcSEcCtD
Lisuride—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000867	0.00946	CcSEcCtD
Lisuride—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000829	0.00905	CcSEcCtD
Lisuride—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000818	0.00893	CcSEcCtD
Lisuride—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.000801	0.00874	CcSEcCtD
Lisuride—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.000801	0.00874	CcSEcCtD
Lisuride—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.00823	CcSEcCtD
Lisuride—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000727	0.00794	CcSEcCtD
Lisuride—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000725	0.00791	CcSEcCtD
Lisuride—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00072	0.00786	CcSEcCtD
Lisuride—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000719	0.00785	CcSEcCtD
Lisuride—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000713	0.00779	CcSEcCtD
Lisuride—Methylergometrine—HTR2A—chronic obstructive pulmonary disease	0.000709	0.155	CrCbGaD
Lisuride—Cabergoline—HTR2A—chronic obstructive pulmonary disease	0.000709	0.155	CrCbGaD
Lisuride—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000687	0.0075	CcSEcCtD
Lisuride—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00067	0.00731	CcSEcCtD
Lisuride—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000667	0.00728	CcSEcCtD
Lisuride—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000665	0.00726	CcSEcCtD
Lisuride—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000647	0.00706	CcSEcCtD
Lisuride—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000643	0.00702	CcSEcCtD
Lisuride—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000602	0.00657	CcSEcCtD
Lisuride—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00656	CcSEcCtD
Lisuride—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000598	0.00653	CcSEcCtD
Lisuride—Methysergide—HTR2A—chronic obstructive pulmonary disease	0.000592	0.129	CrCbGaD
Lisuride—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000587	0.00641	CcSEcCtD
Lisuride—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000587	0.00641	CcSEcCtD
Lisuride—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00634	CcSEcCtD
Lisuride—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000578	0.00631	CcSEcCtD
Lisuride—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000576	0.00629	CcSEcCtD
Lisuride—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000568	0.0062	CcSEcCtD
Lisuride—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000568	0.0404	CbGeAlD
Lisuride—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000561	0.00612	CcSEcCtD
Lisuride—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00604	CcSEcCtD
Lisuride—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00604	CcSEcCtD
Lisuride—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000553	0.00603	CcSEcCtD
Lisuride—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000552	0.0393	CbGeAlD
Lisuride—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000552	0.00602	CcSEcCtD
Lisuride—Pergolide—HTR2A—chronic obstructive pulmonary disease	0.000548	0.12	CrCbGaD
Lisuride—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000546	0.00595	CcSEcCtD
Lisuride—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000543	0.00593	CcSEcCtD
Lisuride—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00591	CcSEcCtD
Lisuride—Ergotamine—CYP1A2—chronic obstructive pulmonary disease	0.000541	0.118	CrCbGaD
Lisuride—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00587	CcSEcCtD
Lisuride—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00587	CcSEcCtD
Lisuride—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000537	0.00586	CcSEcCtD
Lisuride—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.00586	CcSEcCtD
Lisuride—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00584	CcSEcCtD
Lisuride—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00053	0.00579	CcSEcCtD
Lisuride—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00053	0.00579	CcSEcCtD
Lisuride—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000527	0.00575	CcSEcCtD
Lisuride—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000526	0.00574	CcSEcCtD
Lisuride—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000523	0.0057	CcSEcCtD
Lisuride—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.0057	CcSEcCtD
Lisuride—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000522	0.0057	CcSEcCtD
Lisuride—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.0057	CcSEcCtD
Lisuride—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.00569	CcSEcCtD
Lisuride—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00566	CcSEcCtD
Lisuride—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00566	CcSEcCtD
Lisuride—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000516	0.0367	CbGeAlD
Lisuride—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000514	0.00562	CcSEcCtD
Lisuride—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00559	CcSEcCtD
Lisuride—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000511	0.00558	CcSEcCtD
Lisuride—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00557	CcSEcCtD
Lisuride—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000508	0.00555	CcSEcCtD
Lisuride—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.00553	CcSEcCtD
Lisuride—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00549	CcSEcCtD
Lisuride—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00538	CcSEcCtD
Lisuride—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00535	CcSEcCtD
Lisuride—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000486	0.0346	CbGeAlD
Lisuride—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000484	0.00528	CcSEcCtD
Lisuride—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000483	0.0344	CbGeAlD
Lisuride—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00518	CcSEcCtD
Lisuride—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000458	0.005	CcSEcCtD
Lisuride—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000458	0.005	CcSEcCtD
Lisuride—Ergotamine—HTR2A—chronic obstructive pulmonary disease	0.000457	0.0999	CrCbGaD
Lisuride—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000453	0.00494	CcSEcCtD
Lisuride—Cough—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00494	CcSEcCtD
Lisuride—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00494	CcSEcCtD
Lisuride—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000449	0.0049	CcSEcCtD
Lisuride—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000449	0.0049	CcSEcCtD
Lisuride—Cough—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00484	CcSEcCtD
Lisuride—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.0048	CcSEcCtD
Lisuride—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00044	0.0048	CcSEcCtD
Lisuride—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.0048	CcSEcCtD
Lisuride—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.00479	CcSEcCtD
Lisuride—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00472	CcSEcCtD
Lisuride—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00471	CcSEcCtD
Lisuride—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00471	CcSEcCtD
Lisuride—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000431	0.00471	CcSEcCtD
Lisuride—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00467	CcSEcCtD
Lisuride—Infection—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00459	CcSEcCtD
Lisuride—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00459	CcSEcCtD
Lisuride—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00454	CcSEcCtD
Lisuride—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000415	0.00453	CcSEcCtD
Lisuride—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.00453	CcSEcCtD
Lisuride—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00451	CcSEcCtD
Lisuride—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00451	CcSEcCtD
Lisuride—Infection—Montelukast—chronic obstructive pulmonary disease	0.000412	0.0045	CcSEcCtD
Lisuride—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00445	CcSEcCtD
Lisuride—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00444	CcSEcCtD
Lisuride—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00433	CcSEcCtD
Lisuride—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00428	CcSEcCtD
Lisuride—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00426	CcSEcCtD
Lisuride—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000389	0.0277	CbGeAlD
Lisuride—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00422	CcSEcCtD
Lisuride—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00418	CcSEcCtD
Lisuride—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00418	CcSEcCtD
Lisuride—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.00416	CcSEcCtD
Lisuride—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000377	0.00412	CcSEcCtD
Lisuride—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.00412	CcSEcCtD
Lisuride—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000376	0.00411	CcSEcCtD
Lisuride—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.00411	CcSEcCtD
Lisuride—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00409	CcSEcCtD
Lisuride—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000369	0.00402	CcSEcCtD
Lisuride—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000368	0.00402	CcSEcCtD
Lisuride—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000367	0.00401	CcSEcCtD
Lisuride—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00399	CcSEcCtD
Lisuride—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00399	CcSEcCtD
Lisuride—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00398	CcSEcCtD
Lisuride—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00398	CcSEcCtD
Lisuride—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00395	CcSEcCtD
Lisuride—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00395	CcSEcCtD
Lisuride—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00395	CcSEcCtD
Lisuride—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00391	CcSEcCtD
Lisuride—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000358	0.0039	CcSEcCtD
Lisuride—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00389	CcSEcCtD
Lisuride—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.00388	CcSEcCtD
Lisuride—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000354	0.00386	CcSEcCtD
Lisuride—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000349	0.0249	CbGeAlD
Lisuride—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00381	CcSEcCtD
Lisuride—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00381	CcSEcCtD
Lisuride—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.0038	CcSEcCtD
Lisuride—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00379	CcSEcCtD
Lisuride—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.00379	CcSEcCtD
Lisuride—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00377	CcSEcCtD
Lisuride—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00376	CcSEcCtD
Lisuride—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00373	CcSEcCtD
Lisuride—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000334	0.00364	CcSEcCtD
Lisuride—ADRB1—lung—chronic obstructive pulmonary disease	0.000333	0.0237	CbGeAlD
Lisuride—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000332	0.0236	CbGeAlD
Lisuride—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.0036	CcSEcCtD
Lisuride—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00359	CcSEcCtD
Lisuride—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000321	0.0228	CbGeAlD
Lisuride—HTR2B—lung—chronic obstructive pulmonary disease	0.000319	0.0227	CbGeAlD
Lisuride—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.00031	0.0221	CbGeAlD
Lisuride—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00332	CcSEcCtD
Lisuride—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00332	CcSEcCtD
Lisuride—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00325	CcSEcCtD
Lisuride—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00313	CcSEcCtD
Lisuride—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000282	0.0201	CbGeAlD
Lisuride—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00306	CcSEcCtD
Lisuride—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00306	CcSEcCtD
Lisuride—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000279	0.0198	CbGeAlD
Lisuride—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00299	CcSEcCtD
Lisuride—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00294	CcSEcCtD
Lisuride—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00294	CcSEcCtD
Lisuride—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00291	CcSEcCtD
Lisuride—Headache—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00289	CcSEcCtD
Lisuride—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00289	CcSEcCtD
Lisuride—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00289	CcSEcCtD
Lisuride—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00289	CcSEcCtD
Lisuride—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00288	CcSEcCtD
Lisuride—Headache—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00284	CcSEcCtD
Lisuride—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000258	0.0184	CbGeAlD
Lisuride—DRD2—lung—chronic obstructive pulmonary disease	0.000258	0.0184	CbGeAlD
Lisuride—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00277	CcSEcCtD
Lisuride—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.00275	CcSEcCtD
Lisuride—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.00275	CcSEcCtD
Lisuride—ADRA2C—lung—chronic obstructive pulmonary disease	0.000251	0.0179	CbGeAlD
Lisuride—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00273	CcSEcCtD
Lisuride—HTR2A—trachea—chronic obstructive pulmonary disease	0.000237	0.0169	CbGeAlD
Lisuride—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00255	CcSEcCtD
Lisuride—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00244	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.00242	CcSEcCtD
Lisuride—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00232	CcSEcCtD
Lisuride—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00231	CcSEcCtD
Lisuride—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00226	CcSEcCtD
Lisuride—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00224	CcSEcCtD
Lisuride—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00223	CcSEcCtD
Lisuride—ADRA2A—lung—chronic obstructive pulmonary disease	0.0002	0.0143	CbGeAlD
Lisuride—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00206	CcSEcCtD
Lisuride—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000183	0.002	CcSEcCtD
Lisuride—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000183	0.002	CcSEcCtD
Lisuride—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00189	CcSEcCtD
Lisuride—HTR2A—lung—chronic obstructive pulmonary disease	0.00017	0.0121	CbGeAlD
Lisuride—Infection—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00181	CcSEcCtD
Lisuride—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Lisuride—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00177	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00176	CcSEcCtD
Lisuride—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00173	CcSEcCtD
Lisuride—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00165	CcSEcCtD
Lisuride—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00164	CcSEcCtD
Lisuride—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00158	CcSEcCtD
Lisuride—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00157	CcSEcCtD
Lisuride—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00157	CcSEcCtD
Lisuride—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00156	CcSEcCtD
Lisuride—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000137	0.0015	CcSEcCtD
Lisuride—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.0013	CcSEcCtD
Lisuride—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00011	0.0012	CcSEcCtD
Lisuride—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00116	CcSEcCtD
Lisuride—Headache—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00114	CcSEcCtD
Lisuride—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.02e-05	0.000118	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.02e-05	0.000118	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.02e-05	0.000118	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000117	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1e-05	0.000116	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1e-05	0.000116	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.96e-06	0.000115	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.95e-06	0.000115	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.92e-06	0.000114	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.9e-06	0.000114	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.84e-06	0.000114	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.81e-06	0.000113	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.69e-06	0.000112	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.68e-06	0.000112	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.64e-06	0.000111	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.62e-06	0.000111	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.62e-06	0.000111	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.61e-06	0.000111	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.61e-06	0.000111	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.57e-06	0.000111	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.53e-06	0.00011	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.52e-06	0.00011	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.52e-06	0.00011	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.47e-06	0.000109	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.45e-06	0.000109	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.45e-06	0.000109	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.38e-06	0.000108	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.36e-06	0.000108	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.36e-06	0.000108	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.3e-06	0.000107	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.26e-06	0.000107	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.22e-06	0.000106	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.17e-06	0.000106	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.12e-06	0.000105	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.02e-06	0.000104	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.02e-06	0.000104	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.94e-06	0.000103	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.9e-06	0.000103	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.85e-06	0.000102	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.79e-06	0.000101	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.75e-06	0.000101	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.73e-06	0.000101	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.67e-06	0.0001	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.65e-06	9.98e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.64e-06	9.98e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.61e-06	9.94e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.61e-06	9.94e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.61e-06	9.94e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.6e-06	9.93e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.59e-06	9.92e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.51e-06	9.82e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.48e-06	9.78e-05	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	8.41e-06	9.71e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.41e-06	9.71e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.41e-06	9.7e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.4e-06	9.69e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.4e-06	9.69e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.22e-06	9.49e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.12e-06	9.38e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	8.07e-06	9.31e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.01e-06	9.25e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.01e-06	9.25e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.93e-06	9.15e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.87e-06	9.08e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.82e-06	9.02e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.81e-06	9.02e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.76e-06	8.96e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.75e-06	8.95e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.72e-06	8.91e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	7.72e-06	8.91e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.69e-06	8.88e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.65e-06	8.83e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.65e-06	8.83e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.65e-06	8.83e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.64e-06	8.82e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.58e-06	8.75e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.57e-06	8.73e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.54e-06	8.7e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.52e-06	8.69e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.38e-06	8.52e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.32e-06	8.45e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.3e-06	8.43e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.29e-06	8.42e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.28e-06	8.4e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.26e-06	8.39e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.23e-06	8.35e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.21e-06	8.32e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.17e-06	8.28e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.11e-06	8.21e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.08e-06	8.17e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.02e-06	8.11e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.99e-06	8.08e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.98e-06	8.06e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.97e-06	8.05e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.97e-06	8.05e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.95e-06	8.02e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.94e-06	8.01e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.91e-06	7.98e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.91e-06	7.97e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.88e-06	7.94e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.8e-06	7.85e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.79e-06	7.83e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.79e-06	7.83e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.76e-06	7.8e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.72e-06	7.76e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.67e-06	7.7e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.65e-06	7.68e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.63e-06	7.66e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.63e-06	7.65e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.6e-06	7.62e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	6.55e-06	7.56e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.54e-06	7.55e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.45e-06	7.45e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.45e-06	7.45e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.45e-06	7.45e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.44e-06	7.43e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.42e-06	7.42e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.35e-06	7.33e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.35e-06	7.33e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.32e-06	7.3e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.31e-06	7.28e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.28e-06	7.25e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	6.27e-06	7.23e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.22e-06	7.18e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.21e-06	7.16e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.18e-06	7.14e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.14e-06	7.09e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.14e-06	7.09e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.13e-06	7.08e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.13e-06	7.08e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.13e-06	7.07e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.03e-06	6.96e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.92e-06	6.84e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.91e-06	6.83e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.91e-06	6.82e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.88e-06	6.79e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.88e-06	6.79e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.85e-06	6.76e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.83e-06	6.73e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.81e-06	6.71e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.8e-06	6.69e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.79e-06	6.68e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.76e-06	6.65e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.75e-06	6.64e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.72e-06	6.61e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.7e-06	6.57e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.67e-06	6.55e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.65e-06	6.52e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.63e-06	6.5e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.62e-06	6.49e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.59e-06	6.46e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.59e-06	6.46e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.59e-06	6.45e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.58e-06	6.45e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.54e-06	6.4e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.51e-06	6.36e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.51e-06	6.36e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.49e-06	6.34e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.44e-06	6.28e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.44e-06	6.28e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.36e-06	6.18e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.35e-06	6.18e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.33e-06	6.15e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.32e-06	6.14e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.24e-06	6.05e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.19e-06	5.99e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.18e-06	5.98e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.13e-06	5.92e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.11e-06	5.9e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.09e-06	5.88e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.06e-06	5.84e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.06e-06	5.84e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.03e-06	5.8e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.02e-06	5.8e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.98e-06	5.74e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.96e-06	5.73e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.96e-06	5.73e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.94e-06	5.7e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.87e-06	5.62e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.86e-06	5.61e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.8e-06	5.55e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.78e-06	5.52e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.76e-06	5.5e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.71e-06	5.44e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.7e-06	5.42e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.69e-06	5.41e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.65e-06	5.37e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.65e-06	5.37e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.65e-06	5.37e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.62e-06	5.34e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.61e-06	5.32e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.57e-06	5.28e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.57e-06	5.27e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.52e-06	5.22e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.48e-06	5.17e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.48e-06	5.17e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.45e-06	5.14e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.42e-06	5.1e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.41e-06	5.09e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.39e-06	5.06e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.36e-06	5.03e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.33e-06	5e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.32e-06	4.99e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.3e-06	4.96e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.29e-06	4.95e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.27e-06	4.93e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.27e-06	4.92e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.22e-06	4.87e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.22e-06	4.87e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.2e-06	4.85e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.2e-06	4.85e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.18e-06	4.83e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.16e-06	4.81e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.16e-06	4.81e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.15e-06	4.79e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.12e-06	4.75e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.11e-06	4.74e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.1e-06	4.73e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.08e-06	4.71e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.87e-06	4.47e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.86e-06	4.46e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.81e-06	4.4e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.81e-06	4.4e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.81e-06	4.4e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.8e-06	4.38e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.79e-06	4.38e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.78e-06	4.36e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.76e-06	4.34e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.73e-06	4.31e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.63e-06	4.19e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.61e-06	4.17e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.51e-06	4.05e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.47e-06	4.01e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.47e-06	4e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.46e-06	3.99e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.44e-06	3.97e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.4e-06	3.92e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.32e-06	3.84e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.31e-06	3.82e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.21e-06	3.71e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.19e-06	3.68e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.16e-06	3.65e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.14e-06	3.62e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.92e-06	3.37e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.87e-06	3.31e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.85e-06	3.29e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.79e-06	3.22e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.67e-06	3.08e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.61e-06	3.01e-05	CbGpPWpGaD
